← Back to headlines
Soleno Therapeutics Stock Soars on $2.9 Billion Merger News
Soleno Therapeutics (SLNO) shares soared by 32% following the announcement of a $2.9-billion merger.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
